| human | Q5 |
| P496 | ORCID iD | 0000-0001-8093-8741 |
| P3829 | Publons author ID | 493831 |
| P1053 | ResearcherID | AFJ-9217-2022 |
| P1153 | Scopus author ID | 6506262444 |
| P69 | educated at | Imperial College London | Q189022 |
| P108 | employer | Imperial College London | Q189022 |
| P734 | family name | Tregoning | Q19929666 |
| Tregoning | Q19929666 | ||
| Tregoning | Q19929666 | ||
| P735 | given name | John | Q4925477 |
| John | Q4925477 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q35049110 | A "prime-pull" vaccine strategy has a modest effect on local and systemic antibody responses to HIV gp140 in mice |
| Q35668694 | A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging |
| Q38797620 | A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease |
| Q90401267 | A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection |
| Q56689869 | A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines |
| Q57094841 | Adjuvanted influenza vaccines |
| Q36540154 | Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development |
| Q92242536 | Antiviral Immune Response as a Trigger of FUS Proteinopathy in Amyotrophic Lateral Sclerosis |
| Q34055489 | CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection |
| Q40707736 | CD71 targeting boosts immunogenicity of sublingually delivered influenza haemagglutinin antigen and protects against viral challenge in mice |
| Q47885783 | Childhood infections, the developing immune system, and the origins of asthma. |
| Q58699767 | Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy |
| Q60949637 | Comparative Metabolomic Sampling of Upper and Lower Airways by Four Different Methods to Identify Biochemicals That May Support Bacterial Growth |
| Q33847809 | Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines |
| Q37194981 | DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease |
| Q40334840 | Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice |
| Q35053675 | Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model |
| Q37547808 | Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system |
| Q33826900 | Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection |
| Q40775298 | Development of a custom pentaplex sandwich immunoassay using Protein-G coupled beads for the Luminex® xMAP® platform |
| Q91033545 | Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children |
| Q34647519 | Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. |
| Q92997467 | Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study |
| Q34771572 | Expression of tetanus toxin Fragment C in tobacco chloroplasts |
| Q49953632 | From parade ground to PI. |
| Q44778100 | Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent. |
| Q31076192 | Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140. |
| Q59060545 | How will you judge me if not by impact factor? |
| Q37273929 | Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium |
| Q40259120 | Inflammatory responses to influenza vaccination at the extremes of age. |
| Q62898063 | Interferon-Induced Transmembrane Protein 1 Restricts Replication of Viruses That Enter Cells via the Plasma Membrane |
| Q33769399 | Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells |
| Q35061979 | Intravaginal immunization using the recombinant HIV-1 clade-C trimeric envelope glycoprotein CN54gp140 formulated within lyophilized solid dosage forms |
| Q41337351 | MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life. |
| Q42575812 | Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose |
| Q90735154 | Modulating airway glucose to reduce respiratory infections |
| Q34797176 | Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice. |
| Q36747814 | Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection |
| Q35757152 | New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC. |
| Q29654260 | No researcher is too junior to fix science. |
| Q55379817 | P02-03. Screening of potential adjuvants for induction of pro-IgA factors. |
| Q30377198 | PHiD-CV induces anti-Protein D antibodies but does not augment pulmonary clearance of nontypeable Haemophilus influenzae in mice. |
| Q35913930 | Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses |
| Q104465822 | Pre-existing influenza specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children |
| Q36276582 | Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection |
| Q90699214 | Pregnancy has a minimal impact on the acute transcriptional signature to vaccination |
| Q81456301 | Protection against tetanus toxin using a plant-based vaccine |
| Q43838051 | RSV 2005: Global impact, changing concepts, and new challenges. |
| Q91670661 | Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection |
| Q89766941 | Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence |
| Q113282916 | Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next? |
| Q33591243 | Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology |
| Q33781375 | Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection |
| Q35024052 | Role of CCL5 (RANTES) in viral lung disease. |
| Q47557151 | Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease. |
| Q47257240 | Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses. |
| Q89802256 | Ten Simple Rules to becoming a principal investigator |
| Q33535780 | The chemokine MIP1alpha/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. |
| Q61835831 | The impact of timing of maternal influenza immunization on infant antibody levels at birth |
| Q36540047 | The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice |
| Q64272273 | The switch between acute and persistent paramyxovirus infection caused by single amino acid substitutions in the RNA polymerase P subunit |
| Q36043882 | Thymic stromal lymphopoietin (TSLP) acts as a potent mucosal adjuvant for HIV-1 gp140 vaccination in mice |
| Q36811968 | Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice. |
| Q99552638 | Vaccines for COVID-19 |
| Q36315800 | Virally delivered cytokines alter the immune response to future lung infections |
Search more.